Manchester Capital Management’s Alkermes ALKS Stock Holding History

Manchester Capital Management’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$708	Hold	20	–	–	﹤0.01%	1192
2025 Q4	$560	Buy	+20	New	+$599	﹤0.01%	1250

Other funds holding ALKS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Manchester Capital Management's ALKS Position: Q1 2026 in Review

Manchester Capital Management held its Alkermes (ALKS) position steady in Q1 2026 at 20 shares worth $708. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

Manchester Capital Management first reported a position in ALKS in Q4 2025 and has held it in 2 quarters since. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

Manchester Capital Management held 20 shares of Alkermes worth $708 as of Q1 2026.
Manchester Capital Management left its Alkermes share count unchanged in Q1 2026.
Alkermes made up ﹤0.01% of Manchester Capital Management's portfolio in Q1 2026, its #1192 holding.
Manchester Capital Management first reported a position in Alkermes in Q4 2025 and has held it in 2 quarters since.
389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.